Communiqués de presse d'Aji Bio-Pharma Communiqués de presse June 30, 2020 Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing En savoir plus June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India En savoir plus May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 En savoir plus May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials En savoir plus April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic En savoir plus March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board En savoir plus September 2, 2019 Information accompanying the revision of the consumption tax rate En savoir plus 29 août 2019 Ajinomoto Bio-Pharma Services acquiert le reste des parts de la coentreprise Granules OmniChem en Inde En savoir plus April 9, 2019 Information on Service Brand Name Change En savoir plus April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center En savoir plus 3 avril 2019 Jean-Baptiste Agnus rejoint l'équipe de direction mondiale d'Ajinomoto Bio-Pharma Services en tant que vice-président des ventes et du marketing En savoir plus March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth En savoir plus Chargement…Afficher plus
